» Articles » PMID: 12419721

Xenon Preserves Neutrophil and Monocyte Function in Human Whole Blood

Overview
Journal Can J Anaesth
Specialty Anesthesiology
Date 2002 Nov 7
PMID 12419721
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Most volatile anesthetics are known to inhibit the oxidative and phagocytic function of neutrophils. In the present study, we investigated the effect of xenon on phagocytosis and respiratory burst activity of neutrophils and monocytes in human whole blood.

Methods: Heparinized whole blood from 22 healthy volunteers was incubated for 60 min in the presence of 65% xenon. Sixty-five percent nitrous oxide was used as a positive control to prove the reliability of our in vitro system. Phagocytosis of fluorescein isothiocyanate labelled, opsonized Escherichia coli (E. coli) by neutrophils and monocytes was measured using flow cytometry. After induction with either N-formyl-methionyl-leucyl-phenylalanine (FMLP), phorbol-12-myristate-13-acetate or opsonized E. coli, respiratory burst activity was assessed by measuring the oxidation of dihydrorhodamine 123 to rhodamine 123 with a flow cytometer.

Results: Exposure of human whole blood to xenon increased the percentage of neutrophils showing phagocytosis (94 +/- 3% vs 92 +/- 4%; P < 0.01), and the amount of ingested bacteria (P < 0.01). Respiratory burst activity in neutrophils and monocytes was not affected by xenon. Nitrous oxide significantly reduced the percentage of neutrophils showing respiratory burst after FMLP stimulation. Furthermore, E. coli-induced stimulation resulted in a decreased number of reacting neutrophils (84 +/- 15% vs 95 +/- 5%; P < 0.05) and monocytes (70 +/- 22% vs 83 +/- 11%; P < 0.05) as well as a reduced production of hydrogen peroxide in both cell lines compared to control.

Conclusion: In contrast to nitrous oxide, xenon preserves neutrophil and monocyte antibacterial capacity in vitro.

Citing Articles

Enhanced Cerebroprotection of Xenon-Loaded Liposomes in Combination with rtPA Thrombolysis for Embolic Ischemic Stroke.

Peng T, Booher K, Moody M, Yin X, Aronowski J, McPherson D Biomolecules. 2023; 13(8).

PMID: 37627321 PMC: 10452377. DOI: 10.3390/biom13081256.


Oral delivery of xenon for cardiovascular protection.

Yin X, Moody M, Hebert V, Klegerman M, Geng Y, Dugas T Sci Rep. 2019; 9(1):14035.

PMID: 31575906 PMC: 6773773. DOI: 10.1038/s41598-019-50515-3.


Variations in the Phagosomal Environment of Human Neutrophils and Mononuclear Phagocyte Subsets.

Foote J, Patel A, Yona S, Segal A Front Immunol. 2019; 10:188.

PMID: 30881356 PMC: 6405516. DOI: 10.3389/fimmu.2019.00188.


Delivery of xenon-containing echogenic liposomes inhibits early brain injury following subarachnoid hemorrhage.

Miao Y, Peng T, Moody M, Klegerman M, Aronowski J, Grotta J Sci Rep. 2018; 8(1):450.

PMID: 29323183 PMC: 5765033. DOI: 10.1038/s41598-017-18914-6.


Persistence of the bacterial pathogen Granulibacter bethesdensis in chronic granulomatous disease monocytes and macrophages lacking a functional NADPH oxidase.

Chu J, Song H, Zarember K, Mills T, Gallin J J Immunol. 2013; 191(6):3297-307.

PMID: 23956436 PMC: 3769460. DOI: 10.4049/jimmunol.1300200.